Penumbra, Inc. is a thrombectomy company, which designs, develops, manufactures, and markets innovative medical products. It offers neurovascular thrombectomy and embolization and access ...

Penumbra, Inc. PEN recently announced the FDA’s clearance and the launch of Lightning Flash 2.0, the next generation computer assisted vacuum thrombectomy (CAVT) system to remove venous thrombus ...

Yahoo Finance Senior Reporter Jennifer Schonberger appears on Morning Brief, live from the White House, to discuss how the president will unveil long-awaited tariffs aimed at bringing ...

Penumbra, Inc. PEN is likely to grow in the coming quarters, backed by the strength exhibited in the Thrombectomy business. Immersive Healthcare business, too, is making significant progress.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Penumbra, Inc. (NYSE:PEN – Get Free Report) saw a large decline in short interest in the month of February. As of February 28th, there was short interest totalling 1,360,000 shares, a decline of ...